Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1101-1110 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|March 11, 2014
Chromatin modifiers and the promise of epigenetic therapy in acute leukemiaS M Greenblatt, S D Nimer
Leukemia|June 13, 2008
The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AMLK Kojima, M Shimanuki, M Shikami, et al.
Leukemia|June 13, 2008
Spongistatin 1: a new chemosensitizing marine compound that degrades XIAPL Schyschka, A Rudy, I Jeremias, et al.
Leukemia|April 15, 2014
Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemiaV Kumar, R Palermo, C Talora, et al.
Leukemia|April 16, 2014
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trialD Rossille, M Gressier, D Damotte, et al.
Leukemia|April 16, 2014
piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myelomaH Yan, Q-L Wu, C-Y Sun, et al.
Leukemia|April 16, 2014
Gene expression profile alone is inadequate in predicting complete response in multiple myelomaS B Amin, W-K Yip, S Minvielle, et al.
Leukemia|August 1, 1989
Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta)N Nara, S Tohda, K Nagata, et al.
Leukemia|March 4, 2021
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasmsAlexandre Guy, Johanne Poisson, Chloe James
Leukemia|March 5, 2021
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemiaBruno Fattizzo, Robin Ireland, Alan Dunlop, et al.
Pageof 963

Showing results (1101-1110 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|March 11, 2014
Chromatin modifiers and the promise of epigenetic therapy in acute leukemiaS M Greenblatt, S D Nimer
Leukemia|June 13, 2008
The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AMLK Kojima, M Shimanuki, M Shikami, et al.
Leukemia|June 13, 2008
Spongistatin 1: a new chemosensitizing marine compound that degrades XIAPL Schyschka, A Rudy, I Jeremias, et al.
Leukemia|April 15, 2014
Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemiaV Kumar, R Palermo, C Talora, et al.
Leukemia|April 16, 2014
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trialD Rossille, M Gressier, D Damotte, et al.
Leukemia|April 16, 2014
piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myelomaH Yan, Q-L Wu, C-Y Sun, et al.
Leukemia|April 16, 2014
Gene expression profile alone is inadequate in predicting complete response in multiple myelomaS B Amin, W-K Yip, S Minvielle, et al.
Leukemia|August 1, 1989
Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta)N Nara, S Tohda, K Nagata, et al.
Leukemia|March 4, 2021
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasmsAlexandre Guy, Johanne Poisson, Chloe James
Leukemia|March 5, 2021
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemiaBruno Fattizzo, Robin Ireland, Alan Dunlop, et al.
Pageof 963